tiprankstipranks
Edgewise weakness on FDA warning letter ‘unwarranted,’ says RBC Capital
PremiumThe FlyEdgewise weakness on FDA warning letter ‘unwarranted,’ says RBC Capital
16d ago
Edgewise says FDA warning letter unrelated to any Edgewise clinical trial, data
Premium
The Fly
Edgewise says FDA warning letter unrelated to any Edgewise clinical trial, data
16d ago
Edgewise moves off lows after stating FDA warning unrelated to company
Premium
The Fly
Edgewise moves off lows after stating FDA warning unrelated to company
16d ago
Edgewise Therapeutics Reports Q3 Progress in Muscle Disease Trials
PremiumCompany AnnouncementsEdgewise Therapeutics Reports Q3 Progress in Muscle Disease Trials
1M ago
Edgewise Therapeutics reports Q3 EPS (36c), consensus (37c)
Premium
The Fly
Edgewise Therapeutics reports Q3 EPS (36c), consensus (37c)
1M ago
Edgewise Therapeutics call volume above normal and directionally bullish
Premium
The Fly
Edgewise Therapeutics call volume above normal and directionally bullish
2M ago
Edgewise Therapeutics price target raised to $42 from $32 at Leerink
PremiumThe FlyEdgewise Therapeutics price target raised to $42 from $32 at Leerink
3M ago
Playtika to acquire SuperPlay, Intel says not selling Mobileye: Morning Buzz
Premium
The Fly
Playtika to acquire SuperPlay, Intel says not selling Mobileye: Morning Buzz
3M ago
RBC Capital says buy Edgewise Therapeutics after EDG-7500 data
Premium
The Fly
RBC Capital says buy Edgewise Therapeutics after EDG-7500 data
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100